Distinct lipid profile in haemolytic anaemia-related gallstones compared with the general gallstone

References

• Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers. 2016;2:1.
   Web of Science ®Google Scholar
• Gutt C, Schläfer S, Lammert F. The treatment of gallstone disease. Dtsch Arztebl Int. 2020;117(9):148–7.
   PubMed Web of Science ®Google Scholar
• Schafmayer C, Hartleb J, Tepel J, et al. Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany. BMC Gastroenterol. 2006;6(1):36.
   PubMedGoogle Scholar
• Bond LR, Hatty SR, Horn ME, et al. Gall stones in sickle cell disease in the United Kingdom. Br Med J (Clin Res Ed). 1987;295(6592):234–236.
   PubMedGoogle Scholar
• Vítek L, Carey MC. New pathophysiological concepts underlying pathogenesis of pigment gallstones. Clin Res Hepatol Gastroenterol. 2012;36(2):122–129.
   PubMed Web of Science ®Google Scholar
• Hartman C, Tamary H, Tamir A, et al. Hypocholesterolemia in children and adolescents with beta-thalassemia intermedia. J Pediatr. 2002;141(4):543–547.
   PubMed Web of Science ®Google Scholar
• Chang CM, Chiu THT, Chang CC, et al. Plant-Based diet, cholesterol, and risk of gallstone disease: a prospective study. Nutrients. 2019;11(2):335.
   PubMed Web of Science ®Google Scholar
• Nuño-Lámbarri N, Barbero-Becerra VJ, Uribe M, et al. Elevated cholesterol levels have a poor prognosis in a cholestasis scenario. J Biochem Mol Toxicol. 2017;31(1):1–6.
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Merat A, Haghshenass M, et al. Plasma lipids in Iranians with sickle cell disease: hypocholesterolemia in sickle cell anemia and increase of HDL-cholesterol in sickle cell trait. Clin Chim Acta. 2006;365(1-2):217–220.
   PubMed Web of Science ®Google Scholar
• Lazarova E, Gulbis B. Influence of diabetes and hypercholesterolemia on laboratory methods for hereditary spherocytosis diagnosis. J Clin Lab Anal. 2022;36(3):e24248.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457.
   PubMed Web of Science ®Google Scholar
• Elmehdawi R. Hypolipidemia: a word of caution. Libyan J Med. 2008;3(2):84–90.
   PubMed Web of Science ®Google Scholar
• Michael H, Davidson VPP. Hypolipidemia. MSD Manual Professional Version 2022.
   Google Scholar
• Liu Y, Jin S, Li Y, et al. Treatment of asymptomatic gallstones in children with hereditary spherocytosis requiring splenectomy. J Pediatr Surg. 2023;58(4):756–761.
   PubMed Web of Science ®Google Scholar
• Güngör A, Yaralı N, Fettah A, et al. Hereditary spherocytosis: retrospective evaluation of 65 children. Turk J Pediatr. 2018;60(3):264–269.
   PubMed Web of Science ®Google Scholar
• Adekile AD, Azab AF, Al-Sharida SI, et al. Clinical and molecular characteristics of Non-Transfusion-Dependent thalassemia in Kuwait. Hemoglobin. 2015;39(5):320–326.
   PubMed Web of Science ®Google Scholar
• He Q, Xue J. [Clinical and experimental studies of adult hereditary spherocytosis]. Zhonghua Yi Xue Za Zhi. 2014;94(8):603–605.
   PubMedGoogle Scholar
• Ekwattanakit S, Siritanaratkul N, Viprakasit V. A prospective analysis for prevalence of complications in thai nontransfusion-dependent Hb E/β-thalassemia and α-thalassemia (Hb H disease). Am J Hematol. 2018;93(5):623–629.
   PubMed Web of Science ®Google Scholar
• Shalev H, Kapelushnik J, Moser A, et al. Hypocholesterolemia in chronic anemias with increased erythropoietic activity. Am J Hematol. 2007;82(3):199–202.
   PubMed Web of Science ®Google Scholar
• Da Costa L, Galimand J, Fenneteau O, et al. Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev. 2013;27(4):167–178.
   PubMed Web of Science ®Google Scholar
• Zhang M, Mao M, Zhang C, et al. Blood lipid metabolism and the risk of gallstone disease: a multi-center study and meta-analysis. Lipids Health Dis. 2022;21(1):26.
   PubMed Web of Science ®Google Scholar
• Wang J, Shen S, Wang B, et al. Serum lipid levels are the risk factors of gallbladder stones: a population-based study in China. Lipids Health Dis. 2020;19(1):50.
   PubMed Web of Science ®Google Scholar
• Völzke H, Baumeister SE, Alte D, et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion. 2005;71(2):97–105.
   PubMed Web of Science ®Google Scholar
• Song Y, Ma Y, Xie F-C, et al. Age, gender, geographic and clinical differences for gallstones in China: a nationwide study. Ann Transl Med. 2022;10(13):735.
   PubMed Web of Science ®Google Scholar
• Van Erpecum KJ. Pathogenesis of cholesterol and pigment gallstones: an update. Clin Res Hepatol Gastroenterol. 2011;35(4):281–287.
   PubMed Web of Science ®Google Scholar
• Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol. 2018;34(2):81–89.
   PubMed Web of Science ®Google Scholar
• Shabanzadeh DM, Sørensen LT, Jørgensen T. Determinants for gallstone formation - a new data cohort study and a systematic review with meta-analysis. Scand J Gastroenterol. 2016;51(10):1239–1248.
   PubMed Web of Science ®Google Scholar